1. Search Result

Search Result

Targets Recommended: GPCR19

Results for "1002101-19-0" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-100775A


    GPR40 GPR84 Metabolic Disease Inflammation/Immunology
    Setogepram (PBI-4050) acts as an orally active agonist for GPR40 and as an antagonist or inverse agonist for GPR84. Setogepram (PBI-4050) decreases renal, liver and pancreatic fibrosis. Setogepram (PBI-4050) exerts anti-fibrotic, anti-inflammatory and anti-proliferative actions.